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Wu HC, Chang CH, Peng HY, Chen GD, Lai CY, Hsieh MC,
Lin TB. EphrinB2 induces pelvic-urethra reflex potentiation via Src
kinase-dependent tyrosine phosphorylation of NR2B. Am J Physiol
Renal Physiol 300: F403–F411, 2011. First published December 8,
2010; doi:10.1152/ajprenal.00520.2010.—Recently, the role of EphB
receptor (EphBR) tyrosine kinase and their ephrinB ligands in pain-
related neural plasticity at the spinal cord level have been identified.
To test whether Src-family tyrosine kinase-dependent glutamatergic
N-methyl-D-aspartate receptor NR2B subunit phosphorylation under-
lies lumbosacral spinal EphBR activation to mediate pelvic-urethra
reflex potentiation, we recorded external urethra sphincter electro-
myogram reflex activity and analyzed protein expression in the
lumbosacral (L6-S2) dorsal horn in response to intrathecal ephrinB2
injections. When compared with vehicle solution, exogenous eph-
rinB2 (5 g/rat it)-induced reflex potentiation, in associated with
phosphorylation of EphB1/2, Src-family kinase, NR2B Y1336 and
Y1472 tyrosine residues. Both intrathecal EphB1 and EphB2 immu-
noglobulin fusion protein (both 10 g/rat it) prevented ephrinB2-
dependent reflex potentiation, as well as protein phosphorylation.
Pretreatment with PP2 (50 M, 10 l it), an Src-family kinase
antagonist, reversed the reflex potentiation, as well as Src kinase and
NR2B phosphorylation. Together, these results suggest the ephrinB2-
dependent EphBR activation, which subsequently provokes Src ki-
nase-mediated N-methyl-D-aspartate receptor NR2B phosphorylation
in the lumbosacral dorsal horn, is crucial for the induction of spinal
reflex potentiation contributing to the development of visceral pain
and/or hyperalgesia in the pelvic area.
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IN THE LUMBOSACRAL DORSAL horn, neurotransmission mediated
by glutamatergic N-methyl-D-aspartate receptors (NMDARs)
has been implicated in processing nociceptive afferent inputs
coming from the lower urinary tract (4, 10). Spinal adminis-
tration of NMDAR agonists has dose-dependently facilitated
the visceromotor reflex, together with pressor responses to
pelvic noxious stimulation (14). Conversely, blockage of
NMDAR using pharmacological antagonists has inhibited pain
behavior caused by irritation of the pelvic viscera (24, 43).
Among subunits of NMDAR, the role of the NR2B subunit in
pain development has been intensively investigated, as elec-
trophysiological studies have demonstrated that phosphoryla-
tion of specific NR2B tyrosine residues is an important deter-
minant for NMDAR-mediated currents (22), which defines the
role of NMDARs in pain-related neural plasticity (3, 17, 18,
20). The signaling of Src kinases, a family of protooncogenic
tyrosine kinases, has been shown to modulate NMDAR-medi-
ated synaptic transmission and plasticity (1). In inflammatory
animal models, the intrathecal administration of Src-family
kinase inhibitors prevented spinal NR2B phosphorylation and
behavior hyperalgesia, implying that Src-dependent phosphory-
lation of NMDAR NR2B subunits plays a crucial role in the
development of postinflammatory pain and/or hyperalgesia (35).
EphB receptors (EphBRs), transmembrane molecules, were
initially identified as guidance cues during neural development
(40). In the last decade, studies have demonstrated that the
interactions between EphBRs and their ephrinB ligands mod-
ulate neural plasticity induction in the mammalian central
nervous system, mainly, but not exclusively, via exhibiting
effects on NMDAR (8, 12). A recent study also demonstrated
that, in association with thermal hyperalgesia, EphBR activation
caused by immunoglobulin fusion protein of ephrinB2 (ephrinB2-
Fc)-induced, Src kinase-dependent NR2B phosphorylation in the
spinal cord (2), suggesting that ephrinB2-EphBR tyrosine kinase
interactions could probably modulate pain signaling via spinal
Src-dependent NMDAR phosphorylation (2).
Although further proof is still needed for the physiological
and/or pathophysiological relevance, the induction of pelvic-
urethra reflex potentiation (15, 16), a form of NR2B phospho-
rylation-dependent neural plasticity (5, 25, 31, 41), has been
linked to the development of visceral pain from pelvic organs
(26, 27, 30, 32, 33). Studies have shown that the activation of
nociceptive afferent fibers expressing transient receptor poten-
tial vanilloid/transient receptor potential ankyrin by the instil-
lation of irritants into the uterus (32, 33) and the descending
colon (29) facilitated pelvic-urethra reflex activity in a cross-
organ manner. Recently, we reported that acute colonic noci-
ceptive stimulation sensitized pelvic-urethra reflex activity via
the upregulation of endogenous ephrinB2 expression, which
activates EphB1 and EphB2 receptors and leads to Src-family
kinase-dependent NR2B phosphorylation in the lumbosacral
spinal cord (26). Accordingly, we hypothesized that the inter-
actions between ephrinB2 and EphBRs, as well as downstream
Src-dependent NR2B phosphorylation, are involved in the
induction of pelvic-urethra reflex potentiation. We tested this
hypothesis with direct spinal application of ephrinB2 and simul-
taneous recordings, which evoked urethra reflex activity in intact
animal preparations, and we analyzed the protein expression/
phosphorylation of the lumbosacral spinal cord. Our results dem-
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onstrated that the activation of EphBR can initiate downstream
phosphorylation of Src-dependent NMDAR NR2B Y1336 and
Y1472 tyrosine residues in the lumbosacral dorsal horn to
mediate the induction of pelvic-urethra reflex potentiation,
which is presumed to underlie the development of pelvic
visceral pain/hyperalgesia.
MATERIALS AND METHODS
Animal Preparations
One hundred and ninety-eight female Sprague-Dawley rats (205–
290 g) were used in the present experiment, which was reviewed and
approved by the Institutional Review Board of Chung-Shan Medical
University in Taiwan. Rats were anesthetized with urethane (1.2 g/kg
ip). A PE-10 catheter was inserted through a slit made at the atlanto-
occipital membrane and passed caudally to the L6-S2 spinal cord,
which is the spinal level regulating urogenital system, for the dispens-
ing of test agents. The left pelvic nerve was dissected and mounted on
a pair of wire electrodes for stimulation. Oligo-/single unit action
potentials in the external urethra sphincter electromyogram (EUSE)
activity were recorded by a pair of wire electrodes and were contin-
uously recorded on a recording system (MP30, Biopac, Santa Barbara,
CA). Single shocks at a fixed suprathreshold strength were repeated at
1 stimulation/30 s [test stimulation (TS)] and given through the
stimulation electrodes.
Application of Drugs
Drugs administered included the following: N-methyl-D-aspartic
acid (NMDA; 10 M, 10 l it, Sigma) (27), a selective glutamatergic
NMDAR agonist; D-2-amino-5-phosphonovalerate (APV, 10 M, 10
l it, Sigma) (27), a glutamatergic NMDAR antagonist; ephrinB2-Fc
chimera (5 g/rat it, Sigma) (2), EphBR ligand; EphB1-Fc chimera
(10 g/rat it, Sigma) (2), EphB1 selective antagonist; EphB2-Fc
chimera (10 g/rat it, Sigma) (7), EphB2 selective antagonist; and
4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolol[3,4-d]pyrimidine (PP2,
50 M, 10 l it, Tocris) (27), a Src-family kinase inhibitor. In all
cases, solvent solutions of identical volume to tested agents were
dispensed to serve as the vehicle control.
Western Blotting
After the experimental procedures have been finished, animals
were decapitated, and the dorsal half of the left spinal cord segments
from L6-S2, the spinal level regulating urogenital system, was dis-
sected because the left pelvic nerve was stimulation. Protein samples
(20 g) were separated on SDS-PAGE (8 and 12%) and transferred to
a nitrocellulose membrane. Membranes were blocked in 5% non-fat
milk and probed with antibodies against ephrinB2 (1:2,000, Santa
Cruz), phosphorylated EphB1/2 (pEphB1/2, 1:2,000, Milipore), phos-
phorlated Src (1:1,000, Milipore), or phosphorylated tyr1336/tyr1472-
NR2B (1:1,000 Milipore). The blots were incubated with horseradish
peroxidase-conjugated antibody (1:2,000) for 1 h at room temperature
and visualized with ECL solution (5 min) followed by film exposure
(2 min). Densitometric analysis of the WB membranes was done with
Science Lab 2003 (Fuji, Japan).
Experimental Protocols
Protocols for assessing effects of various kinds of reagents on
reflex activity were as follows.
Protocol 1: Baseline reflex activity. Single shocks of TS (1 stim-
ulation/30 s) were given through stimulation electrodes for 30 min.
Protocol 2: Agonist-induced reflex potentiation After equilibration
(usually 30 min), vehicle solution, NMDA, or ephrinB2 was injected
via the intrathecal catheter at 2 min before TS onset.
Protocol 3: Pharmacological antagonization. EphB1, EphB2,
EphB1 and EphB2, APV, or PP2 was injected intrathecally 5 min
before, and then ephrinB2 or NMDA was done 2 min before, TS
stimulation onset.
Protocol 4: Effects of NMDA. In some studies, NMDA was intra-
thecally injected after PP2 (5 min before) and ephrinB2 (2 min before)
at 1 min before stimulation onset.
Data Analysis
The reflex excitability was assayed by recording the EUSE result-
ing from the pelvic afferent nerve stimulations. We, therefore, counted
the spike number within 1 min following each shock applied. The
responses at 5, 10, 15, and 30 min were offline analyzed and were
plotted as a line chart, and the evoked activity at 30 min was used to
create the bar charts. The data from each specific time point were
averaged from three evoked events in each animal, and then the data
from all of the animals in this experiment were averaged in the
statistical charts. For the data from the Western blot analysis, the
density of specific bands was measured with a computer-assisted
imaging analysis system (LAS-300; Fuji, Kanagawa, Japan). After
normalized against corresponding loading control bands, the intensity
of specific bands was expressed as percentage of loading control. Data
were analyzed by using SigmaPlot 10.0 (Systat Software, San Jose,
CA). All data in the text and Figs. 1–3 in this study are expressed as
means SE. For serial measurements over time (i.e., spikes of EUSE
and protein expression in response to capsaicin instillation at different
time point), two-way repeated-measures ANOVA was used to assess
changes in values before and after treatment. In other cases, two-way
ANOVA was used to analyze data. In all cases, a post hoc Tukey test
was used to compare means for groups when an adequate F ratio was
achieved, and significance was assigned at a P  0.05.
RESULTS
EphrinB2-Induced Reflex Potentiation
Initial experiments were performed in an attempt to establish
baseline reflex activity and agonist-induced reflex potentiation
in animal preparations. Pelvic afferent nerve TS (1 stimula-
tion/30 s for 30 min) evoked baseline reflex activity with single
Fig. 1. Intrathecal ephrinB2 induces N-methyl-D-aspartic acid (NMDA)-dependent pelvic-urethra reflex potentiation. A: pelvic afferent nerve test stimulation (TS;
1 stimulation/30 s for 1,800 s) evoked baseline reflex activity with single action potentials in the external urethra sphincter electromyogram (EUSE). While
intrathecal vehicle solution (TS  VEH) exhibited no effect on the evoked EUSE activity, intrathecal NMDA (TS  NMDA) and ephrinB2 (TS  ephrinB2)
injections both produced reflex potentiation characterized by an elongated firing evoked by each pulse. Tracing shows reflex activity at 1,600 and 1,800 s
following stimulation onset. B: compared with vehicle solution (VEH), intrathecal ephrinB2 administration (TS  ephrinB2) with concentrations of 1, 5, and
10 g/rat dose-dependently increased the mean spike count evoked by TS. **P  0.01 to VEH, n  7. C: vehicle solution exhibited no effect on the baseline
reflex activity with single spike (TS VEH). Intrathecal NMDA administration statistically increased the mean spike count evoked by TS during the stimulation
period (TS NMDA). **P 0.01 to TS VEH, n 7. Spinal ephrinB2 injection significantly increased the mean spike count that peaked at 15 min following
TS onset and then gradually faded out toward baseline (TS  ephrinB2). **P  0.01 to TS  VEH, n  7. D: compared with vehicle solution (TS  VEH),
intrathecal ephrinB2 injection statistically enhanced the expression of phosphorylated EphB1/2 (pEphB1/2), but not total EphB1 (tEphB1), tEphB2, or -actin
(EphB1, EphB2, and actin, respectively) in the lumbosacral (L6-S2) dorsal horn obtained from animals that received TS (TS  ephrinB2). **P  0.01 to
TS  VEH, n  4.
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action potentials in the EUSE throughout the stimulation pe-
riod (Fig. 1A, TS). Intrathecal administration of NMDA (10
M, 10 l, 2 min before TS onset, Fig. 1, A and C, TS 
NMDA), but not vehicle solution (TS  VEH), produced
reflex potentiation characterized by an elongated firing evoked
by each pulse. We then tested whether spinal administration of
ephrinB2 could also induce reflex potentiation or not. Electro-
physiological recordings in Fig. 1A show the intrathecal
ephinrB2 injection (5 g/rat, 2 min before TS onset, TS 
ephrinB2) provoked reflex potentiation, peaking at 15 min
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following TS onset and then gradually faded out toward the
baseline. We then injected ephrinB2 with concentrations of 1,
5, and 10 g/rat. Compared with vehicle solution, intrathecal
ephrinB2 administrations with these concentrations increased
the mean spike count evoked by the TS in a dose-dependent
manner (Fig. 1B).
EephrinB2 Provokes Spinal EphB1/2 Phosphorylation
We then used immunoblotting to analyze whether ephrinB2
administration induces spinal EphB1/2 phosphorylation. When
compared with vehicle solution (Fig. 1D, TS  VEH), the
intrathecal ephrinB2 injection (5 g/rat, TS  ephrinB2)
statistically enhanced the expression level of pEphB1/2
(pEphB1/2 to EphB1 and EphB2) in the lumbosacral dorsal
horn (L6-S2) of animals that received the TS, while levels of
total EphB1, total EphB2, and -actin (EphB1, EphB2, and
actin, respectively) remained unchanged.
Involvement of EphB1 and EphB2 Receptors
The role of spinal EphB1 and EphB2 receptors in ephrinB2-
dependent reflex potentiation was tested by administering se-
lective Eph1B and Eph2B receptor antagonists, Eph1B-Fc and
Eph2B-Fc, respectively. As described, intrathecal ephrinB2 (5
g/rat, Fig. 2, A and E, TS  ephrinB2), but not vehicle
solution (TS  VEH), induced reflex potentiation character-
ized by an elongated firing in animal preparations. Rather than
vehicle solutions (data not shown), prior administration of
EphB1-Fc (10 g/rat it, 5 min before stimulation onset) and
EphB2-Fc (10 g/rat it, 5 min before stimulation onset) both
prevented ephrinB2-dependent reflex potentiation by decreas-
ing the mean spike count evoked by the TS (TS  EphB1 
ephrinB2 and TS EphB2 ephrinB2, respectively), whereas
neither EphB1-Fc nor EphB2-Fc affected the TS-evoked base-
line reflex activity (Fig. 2, A and D, TS  Eph1B and TS 
Eph2B, respectively). The participation of EphB1/2 in eph-
rinB2-dependent reflex potentiation was further investigated by
immunoblotting analysis. Compared with vehicle solution
(Fig. 3A, TS  VEH), intrathecal ephrinB2 (5 g/rat, bar:
ephrinB2, TS) significantly upregulated the expression of
pEphB1/2 (pEphB2) in the lumbosacral dorsal horn without
affecting the levels of total EphB1 and total EphB2 (EphB1
and EphB2, respectively). Prior EpB1-Fc and EphB2-Fc ad-
ministrations prevented EphB1/2 phosphorylation caused by
ephrinB2 by decreasing pEphB1/2 expression (TS  EphB1
and TS  EphB2, respectively).
Involvement of NMDAR
Then we investigated the role of the interactions between the
EphB1/2 receptor and NMDAR in ephrinB2-dependent reflex
potentiation. Compared with the animals that received the
ephrinB2 injection (5 g/rat, Fig. 2, TS  ephrinB2), the
intrathecal APV (10 M, 10 l) injection prevented the eph-
rinB2-dependent reflex potentiation by decreasing the mean
spike count evoked by the TS (Fig. 2, B and E, TS  APV 
ephrinB2). Furthermore, after both EphB1 and EphB2 had
been blocked by the coadministration of selective antagonists,
Eph1B-Fc and Eph2B-Fc (TS  EphB1  EphB2), intrathecal
NMDA injection (10 M, 10 l) provoked reflex potentiation
characterized by an elongated firing in these preparations
(TS  EphB1  EphB2  NMDA). On the other hand,
immunoblotting showed that prior APV administration failed
to prevent ephrinB2-dependent EphB1/2 phosphorylation in
the lumbosacral dorsal horn (Fig. 3A, TS  APV).
Involvement of Src-Family Kinases
The role of Src-family kinases in ephrinB2-dependent reflex
potentiation was studied using a selective antagonist, PP2.
Electrophysiological recordings showed that, while pretreat-
ment with PP2 (50 M, 10 l it) exhibited no effects on the
TS-evoked baseline reflex activity (TS  PP2), it prevented
ephrinB2-dependent reflex potentiation by decreasing the mean
spike count evoked by the TS (Fig. 2, B and F, TS  PP2 
ephrinB2). Moreover, after ephrinB2-dependent reflex poten-
tiation had been abolished by PP2, intrathecal NMDA reversed
PP2-induced antagonization by increasing the mean spike
count (TS  PP2  ephrinB2  NMDA). The role of Src-
family kinases was further investigated using Western blotting
analysis. Although ephrinB2-dependent EphB1/2 phosphoryla-
tion in the lumbosacral spinal cord was not antagonized by prior
PP2 injection (Fig. 3A, TS  PP2), in the animals that received
Fig. 2. EphB1 and EphB2 receptors are involved in ephrinB2-dependent pelvic-urethra reflex potentiation. A: while intrathecal vehicle solution (TS  VEH)
exhibited no effect on the baseline EUSE activity evoked by pelvic afferent nerve TS (1 stimulation/30 s for 30 min), intrathecal ephrinB2 administration
(TS  ephrinB2) produced reflex potentiation characterized by an elongated firing evoked by each pulse. Neither prior administration of EphB1-Fc (10 g/rat
it) nor EphB2-Fc (10 g/rat it) affected the baseline reflex activity evoked by the TS (TS  Eph1B and TS  Eph2B, respectively), whereas both reagents
prevented ephrinB2-dependent reflex potentiation (TS  EphB1  ephrinB2 and TS  EphB2  ephrinB2, respectively). B: intrathecal pretreatment with
D-2-amino-5-phosphonovalerate (APV) (10 M, 10 l) displayed no effect on the TS-evoked baseline reflex activity (TS  APV), but prevented
ephrinB2-dependent reflex potentiation (TS APV ephrinB2). Intrathecal NMDA injection provoked reflex potentiation (TS EphB1 EphB2 NMDA),
even though EphB1 and EphB2 receptors were both blocked by coadministration of Eph1B-Fc and Eph2B-Fc (TS  EphB1  EphB2). C: while it exhibited
no effects on the TS-evoked baseline reflex activity (TS  PP2), intrathecal pretreatment with PP2 (50 M, 10 l) prevented ephrinB2-dependent reflex
potentiation (TS  PP2  ephrinB2). The PP2-induced antagonization on ephrinB2-dependent reflex potentiation was reversed by spinal NMDA
administration (TS  PP2  ephrinB2  NMDA). D: the mean spike count of EUSE activity evoked by pelvic afferent TS was not affected by all of
the test agents, including vehicle solution (TS  VEH), Eph1B-Fc (TS  EphB1), EphB2-Fc (TS  EphB2), APV (TS  APV), PP2 (TS  PP2), as
well as coadministration of Eph1B-Fc and Eph2B-Fc (TS  EphB1  EphB2, all P  0.05 to TS; N  7). E: compared with vehicle solution (TS 
VEH), intrathecal NMDA (TS  NMDA, **P  0.01 to TSVEH, n  7) and ephrinB2 (TS  ephrinB2, **P  0.01 to TSVEH, n  7) both
significantly increased the mean spike count evoked by TS. The ephrinB2-dependent increment in spike count was reversed by prior administration of
Eph1B-Fc (TS  EphB1, ##P  0.01 to TS  ephrinB2, n  7), EphB2-Fc (TS  EphB2, ##P  0.01 to TS  ephrinB2, n  7), and APV (TS  APV,
##P  0.01 to TS  ephrinB2, n  7). Spinal NMDA antagonized the reversal of the ephrinB2-dependent spike increment caused by coadministration
of EphB1-Fc and EphB2-Fc (TS  EphB1  EphB2  NMDA, P  0.01 to TS  ephrinB2, n  7). F: compared with vehicle solution (TS  VEH),
intrathecal ephrinB2 (TS  ephrinB2, **P  0.01 to TS  VEH, n  7) significantly increased the mean spike count evoked by TS. The ephrinB2-dependent
increment in spike count was reversed by prior administration of PP2 (TS PP2 ephrinB2, ##P 0.01 to TS ephrinB2, n 7). Spinal NMDA antagonized
the reversal of ephrinB2-dependent spike increment caused by PP2 (TS  PP2  NMDA, P  0.01 to TS  ephrinB2, n  7).
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the TS, immunoblotting showed that the expression level of
phosphorylated Src (Fig. 3B) but not total Src had increased
significantly due to the intrathecal ephrinB2 administration (5
g/rat, bar: ephrinB2 TS) compared with those given vehicle
solution (TS  VEH). Pretreatment with EpB1-Fc, EphB2-Fc,
and PP2 (TS  EphB1, TS  EphB2, and TS  PP2, respec-
tively) but not APV (TS  APV) prevented ephrinB2-dependent
Src phosphorylation in the lumbosacral dorsal horn.
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The Role of NMDAR NR2B Subunit
The involvement of Src-mediated phosphorylation of NR2B
Y1336 and Y1472 tyrosine residues in ephrinB2-dependent
reflex potentiation was explored using Western blotting anal-
ysis. Compared with intrathecal vehicle solution (Fig. 3C,
TS  VEH), ephrinB2 enhanced the expression of phosphor-
ylated Y1336 and phosphorylated Y1472 without affecting the
level of total NR2B in the lumbosacral dorsal horn of animals
that received the TS. All of the prior EpB1-Fc, EphB2-Fc, and
PP2 treatments (TS  EphB1, TS  EphB2, and TS  PP2,
respectively) prevented ephrinB2-dependent NR2B Y1336 and
Y1472 phosphorylation in the lumbosacral spinal cord.
DISCUSSION
In this study, we found ephrinB2 administration in the
lumbosacral spinal cord induced pelvic-urethra reflex potenti-
ation with corroboration by EphB1/2, Src-family kinases, as
well as phosphorylation of NR2B Y1336 and Y1472 tyrosine
Fig. 3. Src-dependent NR2B phosphorylation
mediates ephrinB2-dependent EphB1/2 phos-
phorylation in the lumbosacral (L6-S2) dorsal
horn. A: compared with vehicle solution (TS
VEH), intrathecal ephrinB2 injection (bar:
ephrinB2) statistically enhanced the expression
of pEphB1/2, but not tEphB1 and tEphB2, in
the lumbosacral dorsal horn obtained from
animals that received TS. *P  0.05 to
TSVEH, n  4. Prior administration of
EpB1-Fc (TS EphB1, #P 0.05 to TS, n
4) and EphB2-Fc (TS EphB2, #P 0.05 to
TS, n 4), but not PP2 (TS PP2, P 0.05
to TS, n 4) and APV (TS APV, P 0.05
to TS, n  4), prevented ephrinB2-dependent
EphB1/2 phosphorylation. B: compared with
vehicle solution (TS VEH), intrathecal eph-
rinB2 injection (bar: ephrinB2) statistically en-
hanced the expression of phosphorylated
(pSrc) but not total Src in the lumbosacral
dorsal horn obtained from animals that re-
ceived TS. *P  0.05 to TS  VEH, n  4.
Prior administration of EpB1-Fc (TS 
EphB1, #P  0.05 to TS, n  4), EphB2-Fc
(TS  EphB2, #P  0.05 to TS, n  4), and
PP2 (TS PP2, #P 0.05 to TS, n 4), but
not APV (TSAPV, P 0.05 to TS, n 4),
prevented ephrinB2-dependent Src phosphor-
ylation. C: compared with vehicle solution
(TS  VEH), intrathecal ephrinB2 injec-
tion (bar: ephrinB2) statistically enhanced
the expression of phosphorylated Y1336
and Y1472 residues of NR2B, but not total
NR2B (tNR2B), in the lumbosacral dorsal
horn obtained from animals that received
TS. *P  0.05 to TS  VEH, n  4. Prior
administration of EpB1-Fc (TS  EphB1,
#P  0.05 to TS, n  4), EphB2-Fc (TS 
EphB2, #P  0.05 to TS, n  4), and PP2
(TS  PP2, P  0.05 to TS, n  4)
prevented ephrinB2-dependent EphB1/2
phosphorylation.
F408 EPHRINB2/EPHB/SRC/NR2B-DEPENDENT SRP
AJP-Renal Physiol • VOL 300 • FEBRUARY 2011 • www.ajprenal.org
residues. Pretreatment with EphBR selective antagonists pre-
vented agonist-induced reflex potentiation and all protein phos-
phorylation. Intrathecal application of a Src-family kinase
inhibitor blocked reflex potentiation, which occurred with a
reversal in phosphorylation of Src kinase and NR2B tyrosine
residues. Taken together, these results suggest that induction of
pelvic-urethra reflex potentiation caused by spinal ephrinB2
administration may be, at least in part, due to the phosphory-
lation of specific tyrosine residues of the NMDAR NR2B
subunit caused by a Src-family tyrosine kinase downstream of
EphBR activation at the lumbosacral spinal cord level.
It has been shown that interactions between ephrinB2 and
EphBRs in the spinal cord are required for the onset of somatic
pain and hyperalgesia. Following nerve injury, the expression
of ephrinB2 in dorsal root ganglion (DRG) neurons and the
EphB1 receptor in the dorsal horn were both enhanced in a
time-dependent manner corresponding to the development of
thermal hyperalgesia in adult rats (36, 37). Knock-down of
ephrinB2 using specific short interfering RNA decreased ex-
pression of ephrinB2 in the DRG, along with attenuation of
mechanical allodynia caused by spinal nerve crushing (13).
Intrathecal administration of ephrinB2-Fc chimera to Wistar
rats induced behavioral evidence of thermal hyperalgesia (35).
Conversely, pharmacological antagonization of EphB1 pre-
vented nerve injury-induced dorsal horn neuron hyperexcitabil-
ity and neuropathic pain (37). Not only in somatic pain caused
by injury or inflammation, our study investigating cross talk
between pelvic viscera has demonstrated that acute activation
of transient receptor potential vanilloid 1 expressing nocicep-
tive afferent fibers coming from the descending colon upregu-
lated spinal ephrinB2 expression and simultaneously induced
EphB1/2 phosphorylation in the lumbosacral dorsal horn (28).
In analogy with this study, results showed spinal administra-
tion of ephrinB2 induced lumbosacral EphB1/2 phosphoryla-
tion in association with pelvic-urethra reflex potentiation, a
phenomenon presumed to participate in the development of
pain and/or hyperalgesia in the lower urinary tract. Pharmaco-
logical antagonization of EphB1 and EphB2 receptors pre-
vented EphB1/2 phosphorylation and ephrinB2-dependent re-
flex potentiation. Together, these results suggest that the eph-
rinB2-EphBR interactions in the lumbosacral spinal cord are
required for the onset of visceral pain in the pelvic area.
In the spinal dorsal horn, NMDARs integrate primary affer-
ent inputs and provide mechanisms to amplify nociceptive
signals, leading to the development of neuropathic and/or
postinflammatory pain (6, 19, 40). Although the exact role of
specific NMDAR subunits is still unclear, functional NMDARs
are mostly heteromeric complexes composed of NR1/NR2
subunits in the mammalian central nervous system (21). The
NR1 subunit is obligatory for NMDARs, whereas NR2 sub-
units are essential for calcium ion gating (34), which demon-
strates the functional diversity of NMDARs (7, 11). An immu-
nohistochemical study investigating the development of neu-
ropathic pain has demonstrated that, in the superficial lamina of
the dorsal horn, NR2B phosphorylation at Tyr1472 is crucial
for the development of hyperalgesia (9). Using antibody label-
ing of specific tyrosine residues, our data in the present study
showed that the spinal ephrinB2 injection induced NR2B
phosphorylation at residues Tyr1336 and Tyr1472, along with
urethra reflex potentiation. We propose a possible role of
NMDAR NR2B phosphorylation plays a role in the induction
of visceral pain. In further support of this proposal, a recent
study showed NMDAR NR2B phosphorylation in the lumbo-
sacral spinal cord is essential for cross-organ sensitization
caused by acute viscera irritation (28). However, our data were
obtained from antibody-specific experiments, but there are no
other findings to corroborate our results. Further studies are
needed to clarify the role of phosphorylation in particular
tyrosine residues in spinal reflex potentiation. Moreover, be-
sides Tyr1336 and Tyr1472, there are 23 tyrosine residues in
the carboxyl tail of the NR2B subunit that could be phosphor-
ylated (1). Due to the limitations of this study, it could not be
elucidated whether there are other tyrosine residues involved in
ephrinB2-dependent reflex potentiation. Through Src-family
kinase-dependent modulations of NMDAR, the interaction
between EphBR tyrosine kinases and their ephrinB ligands has
been shown to play a crucial role in pain processing at the
spinal cord level (2, 35). Intrathecal administration of exoge-
nous ephrinB2, which activates EphBR, induced behavioral
thermal hyperalgesia, and increments in the expression of
phosphorylated Src-EphBR complex were both counteracted
by pretreatment with NMDAR antagonist (35). Conversely, an
Src-family inhibitor has been shown to reverse ephrinB2-
induced thermal hyperalgesia and NR2B phosphorylation in
the spinal dorsal horn (2). These results are consistent with our
finding that intrathecal ephrinB2 induced reflex potentiation in
association with Src-family kinases and NMDAR NR2B phos-
phorylation in the lumbosacral spinal cord. Pharmacological
blockage of Src-family kinase activity prevented reflex poten-
tiation and NR2B phosphorylation, indicating NMDAR NR2B
phosphorylation downstream of Src-family kinase activation
mediated pain-related spinal neural plasticity. However, Src-
family kinases may target NMDAR subunits other than NR2B
(23); therefore, the role of other NMDAR subunit(s), e.g.,
NR2A, in ephrinB2-dependent reflex potentiation, cannot be
ruled out.
Studies have demonstrated that an intrathecal EphBR acti-
vator can induce thermal hyperalgesia, and mechanical allo-
dynia has been correlated with a reduced long-term spinal
potentiation threshold between nociceptive C afferent fibers
and dorsal horn neurons in naive animals. Conversely, phar-
macological blocking of EphBR using EphB-Fc prevents nerve
injury-induced thermohyperalgesia and mechanical allodynia
and reverses enhanced long-term potentiation. This suggests
that ephrinB2/EphB effects on neuropathic pain depend on
regulation of both neuronal excitability and spinal synaptic
plasticity (37). In clinical scenarios, syndromes of patients
being treated, such as irritable bowel syndrome and chronic
pelvic pain, are usually chronic conditions. In the present
study, we demonstrated the onset of a spinal EphBR-dependent
reflex potentiation 10 min after an ephrinB2 injection, which
lasted for at least 30 min. Although this study offers an animal
model to investigate the spinal neural mechanism underlying
viscero-visceral pain, it is limited by insult acuity and the
subsequent measurement interval. On the other hand, behavior
studies that investigated neuropathic pain caused by sciatic
nerve ligation showed time-dependent upregulation of EphrinB
and EphBR in DRG and dorsal horn neurons, which peaks at 7
days and lasts for 21 days after nerve ligation (2, 36). Further
studies are needed to determine whether the ephrinB2-depen-
dent reflex potentiation plays a role in the induction of acute
injury/inflammation pain and eventually contributes to the
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maintenance of a pain condition or the development of hyper-
algesia/allodynia by establishing pathological neural plasticity.
In conclusion, our findings add to the understanding of the
ephrin/EphBR system, which is an important player in
spinal reflex potentiation, acting as a modulator of NMDAR
in the adult spinal cord in vivo. These results help bring to
light the mechanisms underlying reflex potentiation in the
spinal cord, which is considered essential to the induction of
visceral pain.
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